Literature DB >> 23105684

Induction of diabetes by Streptozotocin in rats.

A Akbarzadeh1, D Norouzian, M R Mehrabi, Sh Jamshidi, A Farhangi, A Allah Verdi, S M A Mofidian, B Lame Rad.   

Abstract

The objective of this study is to induce experimental diabetes mellitus by Streptozotocin in normal adult Wistar rats via comparison of changes in body weight, consumption of food and water, volume of urine and levels of glucose, insulin and C-peptide in serum, between normal and diabetic rats. Intra-venous injection of 60mg/kg dose of Streptozotocin in adult wistar rats, makes pancreas swell and at last causes degeneration in Langerhans islet beta cells and induces experimental diabetes mellitus in the 2-4 days. Induction of experimental diabetes mellitus is indeed the first step in the plan of purification of pancreatic Langerhans islet cells of normal rats for transplanting under the testis subcutaneous of experimentally induced diabetic rats. Streptozotocin induces one type of diabetes which is similar to diabetes mellitus with non-ketosis hyperglycemia in some animal species. For induction of experimental diabetes in male adult rats weighted 250-300 grams (75-90 days), 60mg/kg of Streptozotocin was injected intravenously. Three days after degeneration of beta cells, diabetes was induced in all animals. The diabetic and normal animals were kept in the metabolic cages separately and their body weight, consumption of food and water, urine volume, the levels of serum glucose, insulin and C-peptide quantities in all animals were measured and then these quantities were compared. For a microscopic study of degeneration of Langerhans islet beta cells of diabetic rats, sampling from pancreas tissue of diabetic and normal rats, staining and comparison between them, were done. Induction of diabetes with Streptozotocin decreases Nicotinamide-adenine dinucleotide (NAD) in pancreas islet beta cells and causes histopathological effects in beta cells which probably intermediates induction of diabetes. In this study, we used Streptozotocin for our experiments in induction of experimental diabetes mellitus. After Induction of diabetes, consumption of food and water, volume of urine and glucose increased in the diabetic animals in comparison with normal animals, but the weight of body and the volume of insulin and C-peptide decreased in the diabetic animals. Sampling and staining of pancreas tissue of diabetic and normal rats showed that the Langerhans islet beta cells of diabetic rats have been clearly degenerated. In three days, Streptozotocin makes pancreas swell and at last causes degeneration in Langerhans islet beta cells and induces experimental diabetes. It also changes normal metabolism in diabetic rats in comparison with normal rats. Consumption of water and food, volume of urine, serum glucose increases in diabetic animals in comparison with normal rats but the levels of serum insulin, C-peptide and body weight decreases.

Entities:  

Keywords:  Diabetes Induction; Islet cells; Streptozotocin

Year:  2007        PMID: 23105684      PMCID: PMC3453807          DOI: 10.1007/BF02913315

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  9 in total

1.  The metabolic fate and elimination of streptozotocin.

Authors:  E H Karunanayake; D J Hearse; G Mellows
Journal:  Biochem Soc Trans       Date:  1975       Impact factor: 5.407

2.  Maternal semistarvation and streptozotocin-diabetes in rats have different effects on the in vivo glucose uptake by peripheral tissues in their female adult offspring.

Authors:  K Holemans; R Van Bree; J Verhaeghe; K Meurrens; F A Van Assche
Journal:  J Nutr       Date:  1997-07       Impact factor: 4.798

3.  An attempt to reverse diabetes by delayed islet cell transplantation in humans.

Authors:  C Rastellini; R Shapiro; R Corry; J J Fung; T E Starzl; A S Rao
Journal:  Transplant Proc       Date:  1997-06       Impact factor: 1.066

4.  Treatment of streptozotocin-induced diabetes mellitus by transplantation of islet cells plus bone marrow cells via portal vein in rats.

Authors:  Kazuya Ikebukuro; Yasushi Adachi; Yuichiro Yamada; Shimpei Fujimoto; Yutaka Seino; Haruki Oyaizu; Koshiro Hioki; Susumu Ikehara
Journal:  Transplantation       Date:  2002-02-27       Impact factor: 4.939

5.  Tissue distribution of streptozotocin (NSC-85998).

Authors:  B K Bhuyan; S L Kuentzel; L G Gray; T J Fraser; D Wallach; G L Neil
Journal:  Cancer Chemother Rep       Date:  1974 Mar-Apr

Review 6.  Streptozocin: a review of its pharmacology, efficacy, and toxicity.

Authors:  R B Weiss
Journal:  Cancer Treat Rep       Date:  1982-03

7.  Short-term insulin treatment prevents the diabetogenic action of streptozotocin in rats.

Authors:  J Thulesen; C Orskov; J J Holst; S S Poulsen
Journal:  Endocrinology       Date:  1997-01       Impact factor: 4.736

8.  Autoimmune diabetes induced by the beta-cell toxin STZ. Immunity to the 60-kDa heat shock protein and to insulin.

Authors:  D Elias; H Prigozin; N Polak; M Rapoport; A W Lohse; I R Cohen
Journal:  Diabetes       Date:  1994-08       Impact factor: 9.461

9.  Combination chemotherapy of advanced previously treated Hodgkin's disease with streptozotocin, CCNU, adriamycin and bleomycin.

Authors:  J A Levi; P H Wiernik; C H Diggs
Journal:  Med Pediatr Oncol       Date:  1977
  9 in total
  72 in total

1.  Antidyslipidemic Effect of Ocimum sanctum Leaf Extract in Streptozotocin Induced Diabetic Rats.

Authors:  Ishrat Husain; Ramesh Chander; Jitendra Kumar Saxena; Abbas Ali Mahdi; Farzana Mahdi
Journal:  Indian J Clin Biochem       Date:  2014-01-23

2.  Gamma Amino Butyric Acid Attenuates Brain Oxidative Damage Associated with Insulin Alteration in Streptozotocin-Treated Rats.

Authors:  N A Eltahawy; H N Saada; A S Hammad
Journal:  Indian J Clin Biochem       Date:  2016-07-30

3.  Insulin dependent and independent normalization of blood glucose levels reduces the enhanced rewarding effects of nicotine in a rodent model of diabetes.

Authors:  Javier Íbias; Laura E O'Dell; Arbi Nazarian
Journal:  Behav Brain Res       Date:  2018-05-24       Impact factor: 3.332

4.  Effects of concomitant diabetes mellitus and hyperthyroidism on testicular and epididymal histoarchitecture and steroidogenesis in male animals.

Authors:  Nazar Ali Korejo; Quan-Wei Wei; Atta Hussain Shah; Fang-Xiong Shi
Journal:  J Zhejiang Univ Sci B       Date:  2016 Nov.       Impact factor: 3.066

5.  A Therapeutic Insight of Niacin and Coenzyme Q10 Against Diabetic Encephalopathy in Rats.

Authors:  Tarek K Motawi; Hebatallah A Darwish; Manal A Hamed; Nagy S El-Rigal; Asmaa F Aboul Naser
Journal:  Mol Neurobiol       Date:  2016-02-11       Impact factor: 5.590

6.  Immunoisolated transplantation of purified langerhans islet cells in testis cortex of male rats for treatment of streptozotocin induced diabetes mellitus.

Authors:  Ali Farhangi; Dariush Norouzian; Mohammad Reza Mehrabi; Mohsen Chiani; Zahra Saffari; Maryam Farahnak; Azim Akbarzadeh
Journal:  Indian J Clin Biochem       Date:  2013-05-15

7.  Brain heparan sulphate proteoglycans are altered in developing foetus when exposed to in-utero hyperglycaemia.

Authors:  M S Sandeep; C D Nandini
Journal:  Metab Brain Dis       Date:  2017-05-02       Impact factor: 3.584

8.  Lentiviral gene therapy vectors encoding VIP suppressed diabetes-related inflammation and augmented pancreatic beta-cell proliferation.

Authors:  Fulya Erendor; Elif Ozgecan Sahin; Ahter D Sanlioglu; Mustafa Kemal Balci; Thomas S Griffith; Salih Sanlioglu
Journal:  Gene Ther       Date:  2020-07-30       Impact factor: 5.250

9.  Ameliorative effect of kaempferol, a flavonoid, on oxidative stress in streptozotocin-induced diabetic rats.

Authors:  Khalid S Al-Numair; Govindasamy Chandramohan; Chinnadurai Veeramani; Mohammed A Alsaif
Journal:  Redox Rep       Date:  2014-12-12       Impact factor: 4.412

10.  The effect of in vivo mobilization of bone marrow stem cells on the pancreas of diabetic albino rats (a histological & immunohistochemical study).

Authors:  Zeinab Mohamed Kamel Ismail; Ashraf Mahmoud Fawzy Kamel; Mira Farouk Youssef Yacoub; Alshaymaa Gamal Aboulkhair
Journal:  Int J Stem Cells       Date:  2013-05       Impact factor: 2.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.